Prevalence and Susceptibility of Shigella Species to 11 Antibiotics in a Kuwait Teaching Hospital

REFERENCES

• Dupont HL. Shigella species (bacillary dysentery). In: Mandell G, Douglas, G, Bennett JE,eds. Principles and Practice of Infectious Diseases. London, Churchill Livingstone, 1995: 2033–2039.
   Google Scholar
• Vila J, Gascon J, Abdalla S, et al. Antimicrobial resis-tance of Shigella isolates causing traveler's diarrhoea. Antimicrob Agents Chemother 1994; 38: 2668–2670.
   PubMed Web of Science ®Google Scholar
• Tauxe RV, Puhr ND, Wells JG, Hargrett-Bean N, Blake PA. Antimicrobial resistance of Shigella isolates in the USA: Importance of international travelers. J Infect Dis 1990; 162: 1107–1111.
   PubMed Web of Science ®Google Scholar
• Bennish ML, Salam MA, Hossain MA, et al. Antimicrobial resistance of Shigella isolates in Bangladesh, 1983-1990: increasing frequency of strains multiply resistant to ampicillin, trimethoprim/sulfamethoxazole and nalidixic acid. Clin Infect Dis 1992; 14: 1055–1060.
   PubMed Web of Science ®Google Scholar
• Pal SC. Epidemic bacillary dysentery in West Bengal, India (letter). Lancet 1984; 1: 1462.
   PubMed Web of Science ®Google Scholar
• Bennish ML, Salam MA, Jesudason MV, John J. Therapy for shigellosis. II. Randomized double-blind compari-son of ciprofloxacin and ampicillin. J Infect Dis 1990; 162: 711–716.
   Google Scholar
• Lolekha S, Vibulbandhitkit S, Poonyarit P. Response to antimicrobial therapy for shigellosis in Thailand. Rev Infect Dis 1991; 13 (suppl.4): S342-346.
   Google Scholar
• Frost JA, Willshaw GA, Barclay EA, Lemmens P, Vandepitte J. Plasmid characterization of drug-resistant Shigella dysenteriae 1 from an epidemic in central Africa. J Hyg 1995; 94: 163–172.
   Google Scholar
• Centers for Disease Control. Multiply resistant shigellosis in a day-care center-Texas. MMWR 1986; 35: 753–755.
   Google Scholar
• Centers for Disease Control. Nation-wide dissemination of multiply resistant Shigella sonnei following a common-source outbreak. MMWR 1987; 36: 633–634.
   PubMedGoogle Scholar
• Centers for Disease Control. Shigella dysenteriae type 1 - Guatemala. MMWR 1991; 40: 421–428.
   PubMedGoogle Scholar
• Bratoeva MP, John JFJr. In vivo R-plasmid transfer in a patient with mixed infection of shigella dysentery. Epidemiol Infect 1994; 112: 247–252.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards, Approved Standard (NCCLS) Doc. M7-A3, Methods for dilu-tion antimicrobial susceptibility test for bacteria that grow aer-obically, 3rd edition. ISBN 1-56238-209-8, Villanova, PA, 1993;17-20.
   Google Scholar
• Kambal AMM, Chowdhury NH, Al-Eissa YA, Eltigani MMT. Susceptibility of Shigella species to various antimicro-bial agents in Saudi Arabia. Med Sci Res 1994; 22: 867–869.
   Google Scholar
• Kagalwalla AF, Khan SN, Kagalwalla YA, Alola S, Yaish H. Childhood shigellosis in Saudi Arabia. Pediatr Infect Dis J 1992; 11: 215–219.
   PubMed Web of Science ®Google Scholar
• Ling J, Kam KM Lam AW, French GL. Susceptibilities of Hong Kong isolates of multiply resistant Shigella spp. to 25 antimicrobial agents, including ampicillin plus sulbactam and new 4-quinolones. Antimicrob Agents Chemother 1988; 32: 20-23.
   Google Scholar
• Harnett N. High level resistance to trimethoprim cotrimoxazole and other antimicrobial agents among clinical iso-lates of Shigella species in Ontario, Canada - an update. Epidemiol Infect 1992; 109: 463–472.
   PubMed Web of Science ®Google Scholar
• Michail IS, Fox E, Haberberger RL, Ahmed MH, Abbatte EA. Epidemiology of bacterial pathogens associated with infectious diarrhoea in Djibouti. J Clin Microbiol 1990; 28: 956–961.
   PubMed Web of Science ®Google Scholar
• Kain KC, Bartelouk RL, Kelly MT, et al. Etiology of childhood diarrhea in Beijing, China. J Clin Microbiol 1991; 29: 90–95.
   PubMed Web of Science ®Google Scholar
• Casalino M, Yusuf MW, Nicoletti M et al. A two-year study of enteric infections associated with diarrhoeal diseases in children in urban Somalia. Trans R Soc Trop Med Hyg 1988; 82: 637–641.
   Google Scholar
• Ogunsanya TI, Rotimi VO, Adenuga A. A study of the aetiological agents of childhood diarrhoea in Lagos, Nigeria. J Med Microbiol 1994; 40: 10–14.
   PubMed Web of Science ®Google Scholar
• Hyams KC, Bourgeois AL, Merrell BR et al. Diarrheal disease during Operation Desert Shield. N Engl J Med 1991; 325: 1423–1428.
   Google Scholar
• Katouli M, Pachenary A, Jaafari A et al. The role of Shigella spp. in childhood diarrhoea in Iran and their antibiot-ic resistance. Scand J Infect Dis 1989; 21: 415–419.
   Google Scholar
• Admoni O, Yagupsky P, Golan A, Kenes Y, Schifroni G, Horowitz I. Epidemiological, clinical and microbiological features of shigellosis among hospitalized children in northern Israel. Scand J Infect Dis 1995; 27: 139–144.
   PubMed Web of Science ®Google Scholar
• Chugh TD, Suheir A, Mahboob AG, Neil L, El-Bishbishi E. Plasmid-mediated drug resistance of shigellae in Kuwait. Antonie Van Leeuwenhoek 1985; 51: 241–247.
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Pollard RA, Feldman RA. Shigella infec-tions in the United States, 1974-1980. J Infect Dis 1983; 47: 771–755.
   Google Scholar
• Olukoya DK, Oni O. Plasmid profile analysis and antimicrobial susceptibility patterns of shigella isolates from Nigeria. Epidemiol Infect 1990; 105: 59–64.
   PubMed Web of Science ®Google Scholar
• Sack RB, Rahman M, Yunus M, Khan EH. Antimicrobial resistance in organisms causing diarrhoeal dis-ease. Clin Infect Dis 1997; 24 (Suppl. 1): S102-105.
   Google Scholar
• Araj GF, Uwaydah MM, Alami SY. Antimicrobial sus-ceptibility patterns of bacterial isolates at American University Medical Center in Lebanon. Diagn Microbiol Infect Dis 1994; 20: 151–158.
   PubMed Web of Science ®Google Scholar
• Alkan M, Salzstein E, Simu A. Four cases of Shigella septicemia in Israel. Eur J Clin Microbiol 1985; 4: 417–418.
   PubMedGoogle Scholar
• Ruderman JW, Stoller KP, Pomerance JJ. Blood stream invasion of Shigella sonnei in an asymptomatic new-born infant. Pediatr Infect Dis 1986; 5: 379–380.
   PubMedGoogle Scholar
• Hooper DC, Wolfson MA. Flouroquinolones: pharma-cology, clinical uses and toxicities in humans. Antimicrob Agents Chemother 1985; 28: 716–721.
   PubMed Web of Science ®Google Scholar
• Acar JF, Goldstein FW. Trends in bacterial resistance to flouroquinolones. Clin Infect Dis 1995; 24 (Suppl. 1): S67-73.
   Google Scholar